Dr. Alex von Frankenberg served as Managing Director of the High-Tech Gründerfonds (HTGF) from October 2005 until his. See sector focus and contact routes.
Dr. Alex von Frankenberg served as Managing Director of the High-Tech Gründerfonds (HTGF) from October 2005 until his contract expired in autumn 2025, having previously worked as a Venture Manager at Siemens Technology Accelerator and held roles in IT startups and consulting. As HTGF’s leader, he directed investments in young companies across industrial and digital tech, life sciences, and chemical sectors, focusing on startups no older than three years that had received under €500,000 in prior capital. HTGF typically invests at the seed stage, with over 760 seed investments made since 2005, and acts as a lead investor in early-stage deals across Germany and Europe. Notable portfolio companies include Celion Biosciences, Biohit, and several others spun out from HTGF’s extensive network, though specific named examples beyond sector focus are not detailed in available sources. Frankenberg has publicly emphasized that major global startups will eventually emerge from Germany, reflecting his long-term view on the country’s innovation potential. He is set to join May Ventures as a Venture Partner in 2025, shifting toward a KI-focused early-stage fund.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Bonn when building a target list.
Investors like Alex von Frankenberg · Full investor directory · Investor access · Company funding database